![]() |
市場調查報告書
商品編碼
2016736
骨整合植入市場規模、佔有率、趨勢和預測:按產品、材料、最終用戶和地區分類,2026-2034年Osseointegration Implants Market Size, Share, Trends and Forecast by Product, Material, End User, and Region, 2026-2034 |
||||||
2025年全球骨整合植入市場規模為74.737億美元。展望未來,IMARC Group預測,該市場將以4.85%的複合年成長率從2026年成長至2034年,到2034年達到115.971億美元。目前,北美市場佔據主導地位,預計2025年市佔率將超過55.8%。推動該市場成長的主要因素包括人口老化、牙科和整形外科手術需求增加、植入技術進步、口腔衛生意識增強、醫療基礎設施擴建以及優惠的醫保報銷政策實施。
整形外科和牙科疾病的日益普遍,以及對先進植入解決方案的迫切需求,推動了全球骨整合植入市場的發展。此外,致命交通事故的增加以及骨關節炎和類風濕性關節炎患者人數的增多,也帶動了關節和膝關節關節重建手術的需求。這導致消費者越來越傾向於微創手術(MIS),從而促進了市場成長。同時,治療方法提高植入物的耐用性、生物相容性和功能性,也在推動市場發展。例如,2024年3月28日,Osstem Implant推出了TSIII SOI植入,該植入物採用新一代超骨整合(SOI)表面處理技術,可促進癒合並增強早期骨形成。這項新型表面處理技術利用紫外線和HEPES緩衝液形成超親水塗層,增強生物相容性,並將骨整合期從長達六個月縮短至約兩個月。此外,醫療保健成本上升、政府支持政策以及微創手術技術的日益普及促進了已開發市場和新興市場對骨整合植入的廣泛應用,這些因素也推動了市場成長。
美國市場深受運動相關損傷和創傷發生率不斷上升的影響,這些損傷和創傷需要先進的植入解決方案來進行復健治療。糖尿病和血管疾病等慢性疾病發病率的上升(通常會導致截肢)也推動了對骨整合義肢系統的需求。此外,完善的醫療基礎設施和健全的報銷政策促進了醫療專業人員和患者對這些先進植入的接受。同時,對美容和重組手術的需求不斷成長,尤其是那些尋求功能和美觀改善的人群,也促進了市場成長。美國醫療設備製造商的大量研發活動以及該國骨整合植入技術的創新也是推動市場成長的因素。例如,2024年9月9日,SINTX Technologies公司收到美國專利商標局(USPTO)的專利授權通知,該專利涉及一種將生物活性氮化矽鍵合到氧化鋯增強氧化鋁(ZTA)表面的方法。該公司不斷拓展其智慧財產權組合,目前擁有16項美國專利。
骨骼相關疾病增加
骨關節炎、骨質疏鬆症和先天性骨骼畸形等骨骼疾病發生率的不斷上升,推動了骨整合植入的應用。隨著全球人口老化,對採用骨整合技術的外科手術的需求日益成長,尤其是在牙科和整形外科假體領域。在老年人口比例較高的已開發市場,這種需求更為顯著。根據世界衛生組織(WHO)估計,2019年全球約有5.28億人患有骨關節炎,比1990年增加了113%。此外,73%的骨關節炎患者年齡超過55歲,其中60%為女性。因此,老年族群中骨關節炎盛行率的上升推動了對骨整合植入的需求,因為許多老年人需要進行關節重建等手術。因此,由於人口老化和骨骼疾病的增加,骨整合植入市場正在顯著成長。
技術進步
植入表面材料、塗層和技術的創新正在徹底改變骨整合植入的有效性和效率。生物相容性材料(包括鈦及其合金)的開發,為患者提供耐用性和舒適性,同時提高植入的成功率,並進一步推動市場成長。此外,新型3D列印技術能夠製造個人化植入,圖治療效果並提高患者滿意度。這些創新正在推動醫療機構採用骨整合植入,從而提高其可及性和降低成本。例如,Keystone 植入 Holdings於2023年11月發表的全新GENESIS ACTIVE植入系統就是這些創新的體現。此人工植牙手術解決方案推進了植牙和修復領域的發展。持續的技術進步透過改善患者治療效果和提高整個植入手術的效率,正在推動骨整合植入市場的成長。
對美觀且功能齊全的植入的需求日益成長。
尤其在牙科領域,兼具功能優勢和美觀效果的植入需求日益成長,成為骨整合植牙市場成長要素。骨整合植入能夠永久且自然地取代缺牙的牙齒,在功能和美觀方面均帶來益處。這促使眾多希望改善生活品質的患者對骨整合植牙的需求激增,而這主要得益於醫療保健服務的普及和各地民眾健康意識的提高。世界衛生組織(WHO)發布的《2024年口腔健康報告》持續指出,全球口腔健康問題依然嚴峻。據估計,全球約有20億人患有永久性齲齒,約有5.14億兒童患有乳牙齲齒,因此,對骨整合植入等先進牙科治療方法的需求依然十分旺盛。這種對先進牙科治療日益成長的需求,是推動全球骨整合植入市場擴張的主要動力。
The global osseointegration implants market size was valued at USD 7,473.7 Million in 2025. Looking forward, IMARC Group estimates the market to reach USD 11,597.1 Million by 2034, exhibiting a CAGR of 4.85% from 2026-2034. North America currently dominates the market, holding a market share of over 55.8% in 2025. The market is primarily driven by the increasing aging populations, rising demand for dental and orthopedic procedures, advancements in implant technologies, growing awareness about oral health, expanding healthcare infrastructure, and the implementation of favorable reimbursement policies.
The increasing prevalence of orthopedic and dental disorders, which require advanced implant solutions for effective treatment, is driving the global osseointegration implants market. In addition to this, the increasing number of fatal road traffic accidents and the growing number of individuals suffering from osteoarthritis and rheumatoid arthritis increases the need for joint and knee replacement surgeries. This leads to increasing consumer preferences for minimally invasive surgeries (MIS), which is propelling the growth of the market. Besides this, growth and innovations related to treatments improving durability, biocompatibility, and functionality, are fueling the market development. For instance, on March 28, 2024, Osstem Implant launched its TSIII SOI implant which boasts of the next-generation Super Osseointegration (SOI) surface treatment that improves healing and strengthens initial bone formation. This new surface treatment uses UV and HEPES buffering agents to create a super-hydrophilic coating that enhances biocompatibility and reduces the osseointegration period from up to six months to about two months. Apart from this, it is supported by the increasing healthcare expenditure, supportive government policies, and the growth in the adoption of minimally invasive surgical techniques for promoting the mass penetration of osseointegration implants in the developed and emerging markets.
The market in the United States is majorly influenced by the growing prevalence of sports-related injuries and trauma cases, which demand advanced implant solutions for rehabilitation and recovery. The rising incidence of chronic conditions like diabetes and vascular diseases, often leading to limb amputations, drives the demand for osseointegrated prosthetic systems. Moreover, a well-established healthcare infrastructure and strong reimbursement policies promote the adoption of these advanced implants among healthcare providers and patients. Additionally, the rising demand for cosmetic and reconstructive surgeries, particularly among individuals seeking functional and aesthetic enhancements, contributes to market growth. Besides this, the extensive research and development (R&D) activities undertaken by U.S.-based medical device manufacturers and the innovation of osseointegration implant technologies in the country. For example, on September 9, 2024, SINTX Technologies received a notice of allowance for a USPTO patent covering methods to bond bioactive silicon nitride to zirconia-toughened alumina (ZTA) surfaces. The company continues to grow its intellectual property portfolio, now holding 16 U.S. patents.
Growing Prevalence of Bone-related Disorders
Increasing incidences of bone conditions such as osteoarthritis, osteoporosis, and congenital anomalies are contributing factors to the use of osseointegration implants. An ever-growing elderly global population increases the desire for surgical operations using osseointegration processes, especially on dental and orthopedic prosthetics. There is an intensified demand for developed markets that account for older populations in their demographic groups. The World Health Organization estimates that around 528 million people across the globe were living with osteoarthritis in 2019, a 113% increase from 1990. In addition, 73% of individuals with osteoarthritis are aged 55 years and above. Moreover, 60% of these individuals are women. As a result, this increased prevalence of osteoarthritis among the elderly population is driving up the need for osseointegration implants since most of these patients require procedures like joint replacements. Thus, the osseointegration implants market is growing considerably due to an ageing population and a growing number of bone disorders.
Technological Advancements
Innovations in the materials, coatings, and techniques of implant surface are revolutionizing the efficacy and efficiency of osseointegration implants. Growth in the market is further fueled by the development of biocompatible materials, including titanium and its alloys, that ensure higher success rates for such implants, with patients experiencing durability and comfort. Also, the new 3D printing technologies are offering the possibility to create customized implants, thus bettering outcomes and patient satisfaction. These innovations increase osseointegration implant uptake by healthcare service providers and ease accessibility as well as their cost. Keystone Dental Holdings rolled out the GENESIS ACTIVE Implant System during November 2023. An example of such innovation is seen with the advancement of the new GENESIS ACTIVE Implant System, with Keystone Dental Holdings announcing it in November 2023. This dental implant surgical solution advances placement and restoration for the sector. Continued technological advancements are improving patient outcomes while making the overall process of implant procedures more efficient, and it is driving growth in the osseointegration implants market.
Rising Demand for Aesthetic and Functional Implants
The growing demand for implants that integrate functional advantages with aesthetic enhancement, especially in dental application, acts as a significant growth driver for the osseointegration market. Osseo integration implants provide a permanent and natural replacement of missing teeth that provides both functional and aesthetic advantages. This makes them highly in need among patients looking forward to improving the quality of their life, mainly driven by improving access and awareness in healthcare across the regions. In 2024, the World Health Organization report on oral health continues to reflect that oral health issues persist in the global scene. Estimated to have reached several about 2 billion, people suffering from caries in permanent teeth, and approximately 514 million children with caries in primary teeth, continue to present such immense demands for better dental solutions such as osseointegration implants. This growing demand for advanced dental care is a significant driving force behind the expansion of the osseointegration implants market across the world.
Bone-anchored prostheses lead the market in 2025. Bone-anchored prostheses are considered a revolutionary solution for those individuals requiring limb replacement or rehabilitation. The advanced nature of these prosthetic products makes use of osseointegration technology, which involves the direct integration of an implant with bone tissue, thereby offering stability, functionality, and comfort more than socket-based prosthetics. Their growing adoption is due to the increasing prevalence of amputations due to trauma, diabetes, and vascular diseases, coupled with rising awareness about advanced prosthetic options. Users in developed as well as developing markets witness high demand as bone-anchored prostheses can enhance their movement, diminish their pain and even improve the quality of their lives. Besides, the continuous development of implant materials and surgical procedures further enhances their market potential, which makes bone-anchored prostheses a significant product in the osseointegration implant market.
Metallic leads the market with around 63.5% of market share in 2025. Metallic materials are the mainstay of growth in the global osseointegration implants market, as they have excellent biocompatibility, durability, and mechanical strength. The most widely used metals, such as titanium and its alloys, are preferred for their osseointegration capability, especially for establishing a stable bonding with the bone tissue. These materials are resistant to corrosion and wear, which ensures the long-term functionality and reliability of implants used in dental, orthopedic, and maxillofacial applications. The growing need for durable, high-performance implants, especially for the aging population and for patients with trauma or degenerative conditions, gives vital significance to metallic materials in this market. Moreover, novel techniques in metal fabrication, for example, 3D printing and surface coating technologies, positively impact implant customization while further enhancing patient benefits.
Hospitals lead the market with around 65.9% of market share in 2025 due to the extensive provision of different types of medical services and surgical procedures that are provided for patients seeking proper care. Hospitals have an enormous client base with various types of patients in need of osseointegration implants. Patients may suffer from orthopedic, dental, or maxillofacial disorders and could be survivors of trauma and cancer requiring reconstruction solutions. A growth in surgeries combined with hospital admission due to the prevalence of conditions requiring implantation augments the demand for osseointegration implants. In addition to this, government and private investments in hospital facilities, especially in emerging economies, increase access to quality care, which in turn propels the growth of the market. Hospitals' ability to provide complete post-operative care and rehabilitation ensures optimal patient outcomes, which further strengthens their role in the expansion of the osseointegration implant market.
In 2025, North America accounted for the largest market share of over 55.8% due to advanced healthcare infrastructure, high adoption rates of innovative medical technologies, and a well-established regulatory framework. The increasing elderly population in the region and rising cases of trauma, osteoporosis, and dental conditions significantly fuel the demand for osseointegration implants. Countries like the United States and Canada have huge healthcare spending, strong reimbursement policies, and a strong presence of leading industry players, which fosters rapid adoption of advanced implants. Additionally, research and development (R&D) activities are further supported by funding from the government as well as the private sector to enhance product innovation and patient outcomes. With an increase in awareness regarding the advantages of osseointegration and a large percentage of the population suffering from chronic conditions requiring implants, North America is an essential contributor to the growth of the market. Its proactive attitude toward the adoption of cutting-edge medical solutions ensures sustained importance in the global market.
UNITED STATES OSSEOINTEGRATION IMPLANTS MARKET ANALYSIS
The United States is a significant region in the osseointegration implants market with the market share of 89.30% , due to the rise in the number of people with arthritis and mobility problems. According to the CDC, a report in 2024 stated that about 58.5 million adults aged 18 years and older are living with arthritis in the United States, with 25.7 million experiencing activity limitations due to arthritis. The projections indicate that, by 2040, this number will surge to 78 million adults, and this population is surely aged, attributed also to lifestyle, in musculoskeletal conditions. Arthritis is a primary cause of disability and surely does require surgical intervention like joint replacements, where osseointegration implants improve mobility and quality of life. Growing demand for advanced implants made from biocompatible materials, along with the increasing awareness of healthcare, is driving the growth of the market. In addition, efforts to increase access to orthopedic care are expected to boost the demand for osseointegration solutions in the United States.
EUROPE OSSEOINTEGRATION IMPLANTS MARKET ANALYSIS
The Europe osseointegration market is expected to rise significantly due to the aging population in the region and the rise in osteoporosis. On January 1, 2023, the European Union population was 448.8 million, with one-fifth, or 21.3%, aged 65 years or above, according to the European Commission. This indicates the growing needs for medical interventions, such as osseointegration implants, to treat the bone-related condition associated with advancing age. Additionally, osteoporosis remains a serious health issue in Europe, where over 23 million people are at high risk of osteoporotic fractures, as NIH data in 2021 indicates. The majority of such fractures require surgery and implantation, which means the demand for more advanced osseointegration technologies is increased. Moreover, solid healthcare infrastructure combined with innovations happening in implantable materials and surgical techniques increase the success ratio of treatments for osseointegration, giving Europe a large market for its solutions.
ASIA PACIFIC OSSEOINTEGRATION IMPLANTS MARKET ANALYSIS
The Asia Pacific osseointegration implants market has high growth potential, as the region has a rapidly aging population and is witnessing rising osteomyelitis, among other bone-related disorders. According to NIH, the population aged 65 or older in China will grow more than double from 172 million or 12.0% of total population in 2020 to 366 million or 26.0% by 2050. This demographic change gives rise to increasing demand for state-of-the-art healthcare services. This encompasses conditions such as osteoporosis, arthritis, and joint degeneration, in addition to osseointegration implants. Also, the healthcare infrastructure is becoming more advanced within the region. There are enhanced investments in the medical technology space, thus paving the way for growth. It includes Japan-one of the most geriatric countries and India- one of the increasing healthcare conscious ones. Advances in implant materials, including personalized 3D printing of implants, improve success rates. Therefore, osseointegration implants are witnessing significant growth as the leading market area in the Asia Pacific region.
LATIN AMERICA OSSEOINTEGRATION IMPLANTS MARKET ANALYSIS
The Latin American osseointegration implants market is growing due to the increasing orthopedic disorder prevalence, primarily in Brazil. In this region, the growing demand for hip replacement surgeries supports the market expansion. According to estimates from the Brazilian Hip Society, there are about 70,000 hip arthroplasties performed annually. Only 17,000 of them are publicly funded, according to an NCBI report in 2020. Thus, this situation presents a sizeable opportunity for private healthcare service providers to help bridge the ever-growing demand gap for hip replacement and osseointegration implants. The aging population in Latin America and the rising awareness of advanced medical technologies are also contributing to the need for high-quality orthopedic implants. As more patients seek personalized and long-lasting solutions for conditions like osteoarthritis and osteoporosis, the market for osseointegration implants in Latin America is expected to continue its growth. The region is heading for tremendous gains in implant technology and patient care, thus offering some great opportunities that are expected in the coming years.
MIDDLE EAST AND AFRICA OSSEOINTEGRATION IMPLANTS MARKET ANALYSIS
The Middle East and Africa (MEA) osseointegration implants market is witnessing significant growth with the increasing incidence of bone-related disorders like osteoarthritis (OA) and rising investments in healthcare. According to the NIH, the standardized prevalence of OA in the MENA region was 5,342.8 cases per 100,000 in 2019. This number rose by 9.3% from 1990. The growing case of OA, which is greatly promoted through the aging population, fuels the need for joint replacement surgeries, a scenario where osseointegration implants are fundamental. Additional strength to the increased demand for superior medical technologies that include osseointegration implants is provided with the increasing regional healthcare spending-estimated to stand at USD 135.5 Billion by the year 2027 in GCC, as per reports. Moreover, the rising preference and adoption of innovative and highly biocompatible materials in solutions from implant technology, which is currently enhancing the whole market growth through the MEA region.
The osseointegration implants market at the global level is highly competitive, with key manufacturers focusing on innovation, technology, and differentiation in products. The key companies majorly emphasize the research and development (R&D) activities of implant design, biocompatibility, and long-term durability. Companies have been investing significantly in minimally invasive solutions and personalized implants in order to bring better patient results. Market players are trying to increase their geographies through partnerships, collaboration, and distribution agreements. Rising consumption of advanced materials such as titanium and ceramic help in further innovation. Manufacturers target emerging markets by providing cost-effective solutions, which impact the market dynamics.